NDC 0002-1445 – Taltz
Ixekizumab 80 mg/mL · Injection, Solution · Subcutaneous
Product NDC0002-1445
Product details
- Brand name
- Taltz
- Generic name
- Ixekizumab
- Labeler
- Eli Lilly and Company
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA125521
- Marketed since
- March 22, 2016
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-17A Antagonist
Active ingredients
- Ixekizumab 80 mg/mL
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 0002-1445-09 | 3 SYRINGE in 1 CARTON (0002-1445-09) / 1 mL in 1 SYRINGE (0002-1445-01) | Mar 22, 2016 |
| 0002-1445-11 | 1 SYRINGE in 1 CARTON (0002-1445-11) / 1 mL in 1 SYRINGE (0002-1445-01) | Mar 22, 2016 |
| 0002-1445-27 | 2 SYRINGE in 1 CARTON (0002-1445-27) / 1 mL in 1 SYRINGE (0002-1445-01) | Mar 22, 2016 |
| 0002-1445-61 sample | 1 SYRINGE in 1 CARTON (0002-1445-61) / 1 mL in 1 SYRINGE | Apr 19, 2016 |